These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Histopathologic features in vitiligo. Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112 [TBL] [Abstract][Full Text] [Related]
28. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism. Sasaki M; Kondo M; Sato K; Umeda M; Kawabata K; Takahashi Y; Suzuki T; Matsunaga K; Inoue S Pigment Cell Melanoma Res; 2014 Sep; 27(5):754-63. PubMed ID: 24890809 [TBL] [Abstract][Full Text] [Related]
29. Influence of the frequency of laser toning for melasma on occurrence of leukoderma and its early detection by ultraviolet imaging. Sugawara J; Kou S; Kou S; Yasumura K; Satake T; Maegawa J Lasers Surg Med; 2015 Feb; 47(2):161-7. PubMed ID: 25663133 [TBL] [Abstract][Full Text] [Related]
30. Application of a pigment measuring device--Mexameter--for the differential diagnosis of vitiligo and nevus depigmentosus. Park ES; Na JI; Kim SO; Huh CH; Youn SW; Park KC Skin Res Technol; 2006 Nov; 12(4):298-302. PubMed ID: 17026663 [TBL] [Abstract][Full Text] [Related]
31. Disorders of hypopigmentation in children. Pinto FJ; Bolognia JL Pediatr Clin North Am; 1991 Aug; 38(4):991-1017. PubMed ID: 1870914 [TBL] [Abstract][Full Text] [Related]
32. A Randomized Double Blind Clinical Trial on a Sabgh Formulation for Patients With Vitiligo. Hosseinkhani A; Montaseri H; Sodaifi M; Mohagheghzadeh A; Seradj H; Afshari-Jouybari H J Evid Based Complementary Altern Med; 2015 Oct; 20(4):254-8. PubMed ID: 25851025 [TBL] [Abstract][Full Text] [Related]
36. Effect of Dickkopf1 on the senescence of melanocytes: in vitro study. Rani S; Chauhan R; Parsad D; Kumar R Arch Dermatol Res; 2018 May; 310(4):343-350. PubMed ID: 29442138 [TBL] [Abstract][Full Text] [Related]
37. Melanocyte-specific cytotoxic T lymphocytes in patients with rhododendrol-induced leukoderma. Fujiyama T; Ikeya S; Ito T; Tatsuno K; Aoshima M; Kasuya A; Sakabe J; Suzuki T; Tokura Y J Dermatol Sci; 2015 Mar; 77(3):190-2. PubMed ID: 25724360 [No Abstract] [Full Text] [Related]
38. Rhododendrol-induced leukoderma update I: Clinical findings and treatment. Matsunaga K; Suzuki K; Ito A; Tanemura A; Abe Y; Suzuki T; Yoshikawa M; Sumikawa Y; Yagami A; Masui Y; Inoue S; Ito S; Katayama I J Dermatol; 2021 Jul; 48(7):961-968. PubMed ID: 33686651 [TBL] [Abstract][Full Text] [Related]
39. A unique system that can sensitively assess the risk of chemical leukoderma by using murine tail skin. Iida M; Tazaki A; Deng Y; Chen W; Yajima I; Kondo-Ida L; Hashimoto K; Ohgami N; Kato M Chemosphere; 2019 Nov; 235():713-718. PubMed ID: 31279121 [TBL] [Abstract][Full Text] [Related]
40. Improvement in the quality of life of patients with rhododendrol-induced leukoderma after camouflaging with dihydroxyacetone cream. Matsunaga K; Sasaki M; Okajima T; Miyaki M; Sakaguchi H J Dermatol; 2020 Jul; 47(7):801-802. PubMed ID: 32424834 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]